Chylomicronemia and the chylomicronemia syndrome: A practical approach to management

被引：56

作者：

Leaf, David Alexander ^{[1
]}

机构：

[1] Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90024 USA

来源：

AMERICAN JOURNAL OF MEDICINE | 2008年 / 121卷 / 01期

关键词：

chylomicronemia; lipids; pancreatitis;

D O I：

10.1016/j.amjmed.2007.10.004

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Chylomicronemia is present when triglyceride levels exceed 1000 mg/dL. Chylomicronemia, when accompanied by eruptive xanthoma, lipemia retinalis, or abdominal symptoms, is referred to as the "chylomicronemia syndrome" and can cause acute pancreatitis. Treatment aimed at reducing triglyceride levels includes lifestyle modifications to promote weight loss with diet and physical activity coupled with medications, including fibrates, n-3 polyunsaturated fatty acids, and nicotinic acid. Chylomicronemic patients with acute pancreatitis require insulinization in an inpatient setting to abolish chylomicronemia. (C) 2008 Elsevier Inc. All rights reserved.

引用

页码：10 / 12

页数：3

共 21 条

[1] Effects of pioglitazone on lipid and lipoprotein metabolism [J].

Betteridge, D. John .

DIABETES OBESITY & METABOLISM, 2007, 9 (05) :640-647

[2] CHYLOMICRONEMIA SYNDROME - INTERACTION OF GENETIC AND ACQUIRED HYPERTRIGLYCERIDEMIA [J].

BRUNZELL, JD ;

BIERMAN, EL .

MEDICAL CLINICS OF NORTH AMERICA, 1982, 66 (02) :455-468

[3] Fibrates in 2003: therapeutic action in atherogenic dyslipidaemia and future perspectives [J].

Chapman, MJ .

ATHEROSCLEROSIS, 2003, 171 (01) :1-13

[4] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].

Cleeman, JI ;

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, DR ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497

[5] THE DIETARY-TREATMENT OF HYPERLIPIDEMIA - RATIONALE, TECHNIQUE AND EFFICACY [J].

CONNOR, WE ;

CONNOR, SL .

MEDICAL CLINICS OF NORTH AMERICA, 1982, 66 (02) :485-518

[6] Short-term effects of metformin in type 2 diabetes [J].

Eriksson, A. ;

Attvall, S. ;

Bonnier, M. ;

Eriksson, J. W. ;

Rosander, B. ;

Karlsson, F. A. .

DIABETES OBESITY & METABOLISM, 2007, 9 (04) :483-489

[7]

FLEGAL KM, 2003, JAMA-J AM MED ASSOC, V289, P76

[8] Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey [J].

Ford, ES ;

Giles, WH ;

Dietz, WH .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (03) :356-359

[9] TRANSPORT OF VERY LOW-DENSITY LIPOPROTEIN TRIGLYCERIDES IN VARYING DEGREES OF OBESITY AND HYPERTRIGLYCERIDEMIA [J].

GRUNDY, SM ;

MOK, HYI ;

ZECH, L ;

STEINBERG, D ;

BERMAN, M .

JOURNAL OF CLINICAL INVESTIGATION, 1979, 63 (06) :1274-1283

[10] n-3 Fatty acids and serum lipoproteins: Human studies [J].

Harris, WS .

AMERICAN JOURNAL OF CLINICAL NUTRITION, 1997, 65 (05) :1645-1654

← 1 2 3 →